Marketing-authorisation holder · United States
Navinta LLC
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARMUSTINE100mg/vial · Injectable | Carmustine | United States | Marketed | 2018 |
| DIAZEPAM10mg/2ml (5mg/ml) | 2.5mg/0.5ml (5mg/ml) | 20mg/4ml (5mg/ml) · GEL | Diazepam | United States | Marketed | 2023 |
| FOSAPREPITANT DIMEGLUMINE115mg base/vial | 150mg base/vial · Powder | Aprepitant | United States | Marketed | 2016 |
| MIGLUSTAT100mg · Capsule | Miglustat | United States | Marketed | 2018 |
| RIBAVIRIN6gm/vial · For solution | Ribavirin | United States | Not marketed | 2016 |
| ROPIVACAINE HYDROCHLORIDE5mg/ml(0.5%) · Injectable | Ropivacaine | United States | Marketed | 2014 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 6 |